Integrative Approaches to Ovulation Induction in Polycystic Ovary Syndrome: A Narrative Review of Conventional and Complementary Therapies.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic review methodology or meta-analysis
PubMed 41301804 · doi:10.3390/biomedicines13112711
What was done
This narrative review synthesized current literature on ovulation induction strategies for polycystic ovary syndrome (PCOS). It evaluated conventional pharmacotherapies (clomiphene citrate, letrozole, gonadotropins, insulin-sensitizing agents), complementary modalities (acupuncture, Chinese herbal medicine), and emerging adjuvants (vitamin D, omega-3 fatty acids, sildenafil, antioxidants).
What was found
The abstract reports no quantitative data or specific effect estimates. Qualitatively, letrozole is identified as the most effective first-line monotherapy supported by robust evidence, whereas complementary modalities and nutritional/pharmacologic adjuvants are noted as potential options to enhance endometrial receptivity, clinical pregnancy rates, or manage treatment-resistant cases.
Why it matters
It outlines how integrative and adjunctive strategies can be positioned alongside standard pharmacotherapy for patients experiencing letrozole resistance or seeking non-pharmacologic additions to fertility care.
Limits
The paper is a non-systematic narrative review without reported search protocols, quality appraisal, or quantitative pooling. The abstract does not specify the number of included studies, sample sizes, or adverse effect profiles.
Cited by
- context Polycystic ovary syndrome (PCOS) is the most common cause of female infertility.